Search

everythinglearnresearchcommunity

for

Search:↓

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Peripilar signs can help diagnose androgenetic alopecia and reveal its cause.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.